Modeling and Docking Studies of Toll Like Receptor 7 From Homo Sapiens with Biosynthetic Compounds Rutin and Kaempferol

Shahla Ahmadian¹ , Archana Giri² , Bhuvaneswari Chodisetti³

Section:Research Paper, Product Type: Isroset-Journal
Vol.5 , Issue.5 , pp.138-145, Oct-2018

CrossRef-DOI:   https://doi.org/10.26438/ijsrbs/v5i5.138145

Online published on Oct 31, 2018

Copyright © Shahla Ahmadian, Archana Giri, Bhuvaneswari Chodisetti . This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
 

View this paper at   Google Scholar | DPI Digital Library

XML View     PDF Download

How to Cite this Paper

471 Views    233 Downloads    142 Downloads

Abstract :
Toll-like receptors (TLRs) serve as signaling molecules that identify pathogen-associated molecular patterns (PAMPs) as well as damage-associated molecular patterns (DAMPs), and are expressed by various skin cells including keratinocytes and melanocytes, which are the main cell types involved in both non-melanoma and melanoma skin cancers. A three dimensional model of Toll like receptor 7 from Homo sapiens was generated using 5GMF, as a template with Modeller9v7. With the aid of molecular mechanics and dynamic methods models were generated and checked by Procheck and 3D graph. After energy minimization, the 3D structure of Toll like receptor 7 was compared with a template, and with the aid of the molecular mechanics and molecular dynamics methods, the final models were obtained. Flexible docking studies were performed using a Toll like receptor 7 that is highly expressed with natural inhibitors Rutin and Kaempferol. The results indicated that ARG283, PRO284, LEU286, ILE523, PHE535, MET567, HIS645 in Toll like receptor 7 are important determinant residues in binding process as they have strong hydrogen bonding with these compounds indicating that these are potent inhibitors of toll like receptor 7.

Key-Words / Index Term :
Toll like receptor 7, modeling, molecular dynamics, Homo sapiens, docking studies

References :
[1]. HW Rogers, MA Weinstock, AR Harris, Hinckley MR, SR Feldman , AB Fleischer, et al. "Incidence estimate of nonmelanoma skin cancer in the United States, 2006". Arch Dermatol, Vol 146, Issue 3, pp.283–7, 2010.
[2]. K InYoung, H Yu-Ying " Ultraviolet radiation-induced melanoma skin cancer : Regulation of DNA damage repair and inflammation " Genes & Diseases, Vol.1, Issue.2,pp.118-198,2014.
[3]. PS Karia , J Han, CD Schmults," Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012". J Am Acad Dermatol , Vol 68, Issue 6 , pp.957–66, 2013.
[4]. DR Bickers , HW Lim , D Margolis, MA Weinstock , C Goodman , E Faulkner , C Gould, E Gemmen , T Dall," The burden of skin diseases:2004 a joint project of American Academy of Dermatology Association and Society for Investigative Dermatology ", J Am Acad Dermatol,Vol.55, Issue.3,pp.490-500
[5]. J Alcalay, "The value of Mohs surgery for the treatment of non melanoma skin cancers ", Journal of Cutaneous and Aesthetic Surgery,Vol.5,Issue.1,pp.1-2,2012
[6]. J Bensouliah , P Buck,"Aromadermatology: Aromatherapy in the Treatment and Care of Common Skin Conditions", Radcliffe Publishing Ltd, Abingdon, pp. 1–11, 2006.
[7]. TS Kupper, RC Fuhlbrigge ," Immune surveillance in the skin: mechanisms and clinical consequences ", Nat Rev Immunol,Vol.4,Issue.3,pp.211–22, 2004.
[8]. JG Dinulos, L Mentele, LP Fredericks , BA Dale , GL Darmstadt," Keratinocyte expression of human beta defensin 2 following bacterial infection: role in cutaneous host defense", Clin Diagn Lab Immunol Vol.10,Issue.1,pp.161–6,2003
[9]. WO Chung , BA Dale," Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species". Infect Immun Vol.72, Issue.1,pp.352–8, 2004
[10]. PI Song , YM Park , T Abraham , B Harten , A Zivony, N Neparidze , et al," Human keratinocytes express functional CD14 and toll-like receptor", 4. J. Invest Dermatol ,Vol.119,Issue.2,pp.424–32, 2002.
[11]. K Kawai , H Shimura , M Minagawa , A Ito , K Tomiyama , M Ito," Expression of functional Toll-like receptor 2 on human epidermal keratinocytes".,J Dermatol Sci Vol.30,Issue.3,pp.185–94, 2002.
[12]. BS Baker , JM Ovigne , AV Powles, S Corcoran, L Fry," Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis ". Br J Dermatol ,Vol.148,Issue.4,pp.670–91,2003.
[13]. A Pivarcsi , L Bodai , B Rethi , A Kenderessy-Szabo , A Koreck, M Szell , et al.," Expression and function of Toll-like receptors 2 and 4 in human keratinocytes",Int Immunol,Vol.15,Issue.6,pp.721–30,2003
[14]. MC Lebre , AM van der Aar , L van Baarsen, TM van Capel, JH Schuitemaker , ML Kapsenberg , et al," Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9," J Invest Dermatol,Vol.127,Issue.2,pp.331–41 ,2007
[15]. SH Jin , HY Kang," Activation of Toll-like Receptors 1, 2, 4, 5, and 7 on Human melanocytes modulate pigmentation",Ann Dermatol,Vol. 22,Issue.4,pp.486–91 ,2010.
[16]. S Akira , H Hemmi," Recognition of pathogen-associated molecular patterns by TLR family",Immunol Lett,Vol. 85,Issue.2,pp.85–95 ,2003.
[17]. H Wanger," The immunobiology of the TLR9 subfamily," Trends Immunol ,Vol.25,Issue.7,pp.381–6,2004.
[18]. K Takeda , T Kaisho , S Akira," Toll-like receptors". Annu Rev Immunol ,Vol.2003,Issue. 21,pp.335–76, 2001.
[19]. R Medzhitov,"Toll-like receptors and innate immunity". Nat Rev Immunol ,Vol.1,Issue.2,pp.135–45,2001.
[20]. R Medzhitov, C. Jr Janeway,"Innate immunity", N Engl J Med, Vol.343,Issue.5,pp.338–44, 2000.
[21]. A Iwasaki, R Medzhitov," Toll-like receptor control of the adaptive immune responses", Nat Immunol, Vol. 5,Issue.10 , pp.987–95, 2004.
[22]. S Akira , K Takeda , T Kaisho," Toll-like receptors: critical proteins linking innate and acquired immunity", Nat Immunol ,Vol.2,Issue.8,pp.675–801.2001
[23]. HY Kang , TJ Park, SH Ji,"Imiquimod, a Toll-like receptor 7 agonist, inhibits melanogenesis and proliferation of human melanocytes".,J Invest Dermatol ,Vol.129,Issue.1,pp.243–61, 2009.
[24]. SF Altschul, TL Madden, AA Schaffer, J Zhang, Z Zhang, , W Miller. and D. J Lipman, "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs",Nucleic Acids Res,Vol.25,Issue.7,pp.3389-402,1997.
[25]. , S. B. Needleman and, C. D. Wunsch ,"A general method applicable to the search for similarities in the amino acid sequence of two proteins", J. Mol. Biol, Vol.48, pp.443–453,1970.
[26]. , W. L Jorgensen., J. Chandresekhar, J. D. Madura, R. W. Impey, and M. L.Klein,"Comparison of simple potential functions for simulating liquid water", J. Chem. Phys,Vol.79,pp.926 –935,1983.
[27]. L Kale , R Skeel , M Bhandarkar, R Brunner , A Gursoy , N Krawetz , J Phillips , A Shinozaki, K Varadarajan , K Schulten, " NAMD2: Greater scalability for parallel molecular dynamics", Journal of Computational Physics, Vol.151,Issue.1,pp.283-312, 1999.
[28]. R. A Laskoswki, M W MacArthur, D S Moss and, J. M Thorton," PROCHECK: a program to check the stereochemical quality of protein structures". J. Appl. Cryst,Vol. 26,pp. 283-291,1993.
[29]. , M., J. Schlenkrich, , A. D. Brickmann, , Jr MacKerell ., and M. Karplus," Empirical potential energy function for phospholipids: criteria for parameter optimization and applications. In Biological Membranes: A Molecular Perspective from Computation and Experiment", K. M. Merz and B. Roux, editors, Birkhauser, Boston, MA. pp.31–81,1996.
[30]. J Von Eichborn , MS Murgueitio , M Dunkel , S Koerner, PE Bourne, R Preissner , "PROMISCUOUS: a database for network-based drug-repositioning". Nucleic Acids Reserch.; Vol.39,pp.1060–1066. 2011